Addiction, a disease of compulsion and drive: Involvement of the orbitofrontal cortex

Cerebral Cortex

Volumn 10, Issue 3, 2000, Pages 318-325

  Volkow, Nora D ^a,b,c   Fowler, Joanna S ^a  

^a BROOKHAVEN NATIONAL LABORATORY   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c Medical Department   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE;

ARTICLE; BRAIN METABOLISM; COMPULSION; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; DRIVE; DRUG ABUSE; DRUG DEPENDENCE; HUMAN; ORBITAL CORTEX; PRIORITY JOURNAL; REWARD; THALAMUS; WITHDRAWAL SYNDROME;

EID: 0034016263     PISSN: 10473211     EISSN: None     Source Type: Journal    
DOI: 10.1093/cercor/10.3.318     Document Type: Article

References (86)

1. Ahmed SH, Koob GF (1998) Transition from moderate to excessive drug intake: change in hedonic set point. Science 282:298-300.
2. American Psychiatric Association (1994) Diagnostic and statistical manual for mental disorders. Washington, DC: American Psychiatric Association.
3. Aou S, Oomura Y, Nishino H, Inokuchi A, Mizuno Y (1983) Influence of catecholamines on reward-related neuronal activity in monkey orbitofrontal cortex. Brain Res 267:165-170.
4. Balldin J, Berggren U, Bokstrom K, Eriksson M, Gottfries CG, Karlsson I, Walinder J (1994) Six-month open trial with Zimelidine in alcohol-dependent patients: reduction in days of alcohol intake. Drug Alcohol Depend 35:245-248.
5. Baxter LR, Phelps ME, Mazziotta J (1987) Local cerebral glucose metabolic rates in obsessive compulsive disorder: a comparison with rates in unipolar depression and normal controls. Arch Gen Psychiat 44:211-218.
6. Braun AR, Randolph C, Stoetter B, Mohr E, Cox C, Vladar K, Sexton R, Carson RE, Herscovitch P, Chase TN (1995) The functional neuroanatomy of Tourette's syndrome: an FDG-PET study. II: Relationships between regional cerebral metabolism and associated behavioral and cognitive features of the illness. Neuropsychopharmacology 13:151-168.
7. Brown EE, Robertson GS, Fibiger HC (1992) Evidence for conditional neuronal activation following exposure to a cocaine-paired environment: role of forebrain limbic structures. Neuroscience 12: 4112-4121.
8. Butter CM, Mishkin M, Rosvold HE (1963) Conditioning and extinction of a food rewarded response after selective ablations of frontal cortex in rhesus monkeys. Exp Neurol 7:65-67.
9. Carmichael ST, Price JL (1995) Limbic connections of the orbital and medial prefrontal cortex in macaque monkeys. Comp Neurol 363:615-641.
10. Catafau AM, Etcheberrigaray A, Perez de los Cobos J, Estorch M, Guardia J, Flotats A, Berna L, Mari C, Casas M, Carrio I (1999) Regional cerebral blood flow changes in chronic alcoholic patients induced by naltrexone challenge during detoxification. J Nucl Med 40:19-24.
11. Childress AR, Mozley PD, McElgin W, Fitzgerald J, Reivich M, O'Brien CP (1999) Limbic activation during cue-induced cocaine craving. Am J Psychiat 156:11-18.
12. Coffman, JA, Petty F (1985) Plasma GABA levels in chronic alcoholics. Am J Psychiat 142:1204-1205.
13. Cohen L, Angladette L, Benoit N, Pierrot-Deseilligny C (1999) A man who borrowed cars. Lancet 353:34.
14. Corso TD, Mostafa HM, Collins MA, Neafsey EJ (1998) Brain neuronal degeneration caused by episodic alcohol intoxication in rats: effects of nimodipine, 6,7-dinitro-quinoxaline-2,3-dione, and MK-801. Alcohol Clin Exp Res 22:217-224.
15. Dackis CA, Gold MS (1985) New concepts in cocaine addiction: the dopamine depletion hypothesis. Neurosci Biobehav Rev 9:469-477.
16. 11C-raclopride and positron emission tomography. J Neurosci 12:3773-3780.
17. Dewey SL, Morgan AE, Ashby CR Jr, Horan B, Kushner SA, Logan J, Volkow ND, Fowler JS, Gardner EL, Brodie JD (1998) A novel strategy for the treatment of cocaine addiction. Synapse 30:119-129.
18. Dewey SL, Brodie JD, Gerasimov M, Horan B, Gardner EL, Ashby CR Jr (1999) A pharmacologic strategy for the treatment of nicotine addiction. Synapse 31:76-86.
19. Dringenberg HC, Vanderwolf CH (1997) Neocortical activation: modulation by multiple pathways acting on central cholinergic and serotonergic systems. Exp Brain Res 116:160-174.
20. El-Ghundi M, George SR, Drago J, Fletcher PJ, Fan T, Nguyen T, Liu C, Sibley DR, Westphal H, O'Dowd BF (1998) Disruption of dopamine D1 receptor gene expression attenuates alcohol-seeking behavior. Eur J Pharmacol 353:149-158.
21. Epping-Jordan MP, Watkins SS, Koob GF, Markou A (1998) Dramatic decreases in brain reward function during nicotine withdrawal. Nature 393:76-79.
22. Ferris R, Tang F, Maxwell R (1972) A comparison of the capabilities of isomers of amphetamine, deoxyperadrol and methylphenidate to inhibit the uptake of catecholamines into rat cerebral cortex slices, synaptosomal preparations of rat cerebral cortex, hypothalamus and striatum and into adrenergic nerves of rabbit aorta. J Pharmacol 14:47-59.
23. Fischman MW, Schuster CR, Javaid J, Hatano Y, Davis J (1985) Acute tolerance development to the cardiovascular and subjective effects of cocaine. J Pharmacol Exp Ther 235:677-682.
24. Glowa JR, Rice KC, Matecka D, Rothman RB (1997) Phentermine/fenfluramine decreases cocaine self-administration in rhesus monkeys. NeuroReport 8:1347-51.
25. Grant S, London ED, Newlin DB, Villemagne VL, Liu X, Contoreggi C, Phillips RL, Kimes AS, Margolin A (1996) Activation of memory circuits during cue-elicited cocaine craving. Proc Natl Acad Sci USA 93:12040-12045.
26. Groenewegen HJ (1988) Organization of the afferent connections of the mediodorsal thalamic nucleus in the rat, related to the mediodorsal-prefrontal topography. Neuroscience 24:379-431.
27. Groenewegen HJ, Berendse HW, Wolters JG, Lohman AH (1990) The anatomical relationship of the prefrontal cortex with the striato-pallidal system, the thalamus and the amygdala: evidence for a parallel organization. Prog Brain Res 85:95-116.
28. Haber SN (1986) Neurotransmitters in the human and nonhuman primate basal ganglia. Hum Neurobiol 5:159-168.
29. Haber SN, Kunishio K, Mizobuchi M, Lynd-Balta E (1995) The orbital and medial prefrontal circuit through the primate basal ganglia. J Neurosci 15:4851-4867.
30. Heimer L, Alheid GF, Zaborzky L (1985) The basal ganglia. In: The rat nervous system (Paxinos G, ed), pp 37-74. Sidney: Academic Press.
31. Heinz A, Ragan P, Jones DW, Hommer D, Williams W, Knable MB, Gorey JG, Doty L, Geyer C, Lee KS, Coppola R, Weinberger DR, Linnoila M (1998) Reduced central serotonin transporters in alcoholism. Am J Psychiat 155:1544-1549.
32. Hommer D, Andreasen P, Rio D, Williams W, Ruttimann U, Momenan R, Zametkin A, Rawlings R, Linnoila M (1997) Effects of m-chlorophenylpiperazine on regional brain glucose utilization: a positron emission tomographic comparison of alcoholic and control subjects. J Neurosci 17:2796-2806.
33. Hugdahl K, Berardi A, Thompson WL, Kosslyn SM, Macy R, Baker DP, Alpert NM, LeDoux JE (1995) Brain mechanisms in human classical conditioning: a PET blood flow study. NeuroReport 6:1723-1728.
34. Hunt WA (1983) The effect of ethanol on GABAergic transmission. Neurosci Biobehav Rev 7:87.
35. Insel TR (1992) Towards a neuroanatomy of obsessive-compulsive disorder. Arch Gen Psychiat 49:739-744.
36. Isaac WL, Nonneman AJ, Neisewander J, Landers T, Bardo MT (1989) Prefrontal cortex lesions differentially disrupt cocaine-reinforced conditioned place preference but not conditioned taste aversion. Behav Neurosci 103:345-355.
37. Johnson T, Rosvold HE, Mishkin M (1968) Projections from behaviorally-defined sectors of the prefrontal cortex to the basal ganglia, septum and diencephalon of the monkey. J Exp Neurol 21:20-34.
38. Johnson TN (1971) Topographic projections in the globus pallidus and the substantia nigra of selectively placed lesions in the precommissural caudate nucleus and putamen in the monkey. Exp Neurol 33:584-596.
39. Koob GF, Bloom FE (1988) Cellular and molecular mechanisms of drug dependence. Science 242:715-723.
40. Le Moal M, Simon H (1991) Mesocorticolimbic dopaminergic network: functional and regulatory notes. Physiol Rev 71:155-234.
41. Lewis MJ (1996) Alcohol reinforcement and neuropharmacological therapeutics. Alcohol Alcohol Suppl 1:17-25.
42. Lingford-Hughes AR, Acton PD, Gacinovic S, Suckling J, Busatto GF, Boddington SJ, Bullmore E, Woodruff PW, Costa DC, Pilowsky LS, Ell PJ, Marshall EJ, Kerwin RW (1998) Reduced levels of GABA-benzodiazepine receptor in alcohol dependency in the absence of grey matter atrophy. Br J Psychiat 173:116-122.
43. Loh EA, Roberts DC (1990) Break-points on a progressive ratio schedule reinforced by intravenous cocaine increase following depletion of forebrain serotonin. Psychopharmacology (Berlin) 101:262-266.
44. Madras BK, Kaufman MJ (1994) Cocaine accumulates in dopamine rich regions of primate brain after iv administration: comparison with mazindol distribution. Synapse 18:261-275.
45. Marsden CD, Obeso JA (1994) The functions of the basal ganglia and the paradox of stereotaxic surgery in Parkinson's disease. Brain 117: 877-897.
46. Mc Alonan, G.M., Robbins TW, Everitt BJ (1993) Effects of medial dorsal thalamic and ventral pallidal lesions on the acquisition of a conditioned place preference: further evidence for the involvement of the ventral striatopallidal system in reward-related processes. Neuroscience 52:605-620.
47. McKay JR (1999) Studies of factors in relapse to alcohol, drug and nicotine use: a critical review of methodologies and findings. J Stud Alcohol 60:566-576.
48. Modell JG, Mountz JM, Curtis G, Greden J (1989) Neurophysiologic dysfunction in basal ganglia/limbic striatal and thalamocortical circuits as a pathogenetic mechanism of obsessive compulsive disorder. J Neuropsychiat 1:27-36.
49. Modell JG, Mountz J, Beresford TP (1990) Basal ganglia/limbic striatal and thalamocortical involvement in craving and loss of control in alcoholism. J Neuropsychiat 2:123-144.
50. Nauta WJH (1971) The problem of the frontal lobe: a reinterpretation. J Psychiat Res 8:167-189.
51. 11C] raclopride binding in healthy young adults and schizophrenic patients, reliability and age effects. Hum Psychopharmacol 7:157-165.
52. Oades RD, Halliday GM (1987) Ventral tegmental (A10) system: neuro-biology. 1. Anatomy and connectivity. Brain Res 434:117-65.
53. O'Brien CP, Childress AR, Ehrman R, Robbins SJ (1998) Conditioning factors in drug abuse: can they explain compulsion? Psychopharmacology 12:15-22.
54. Pontieri FE, Tanda G, Orzi F, Di Chiara G (1996) Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature 382:255-257.
55. Porrino LJ, Lyons D (2000) Orbital and medial prefrontal cortex and psychostimulant abuse: studies in animal models. Cereb Cortex 10: 326-333.
56. Portenoy RK, Jarden JO, Sidtis JJ, Lipton RB, Foley KM, Rottenberg DA (1986) Compulsive thalamic self-stimulation: a case with metabolic, electrophysiologic and behavioral correlates. Pain 27:277-290.
57. Ramirez LF, McCormick RA, Russo AM, Taber JI (1983) Patterns of substance abuse in pathological gamblers undergoing treatment. Addict Behav 8:425-428.
58. Ray JP, Price JL (1993) The organization of projections from the mediodorsal nucleus of the thalamus to orbital and medial prefrontal cortex in macaque monkeys. Comp Neurol 337:1-31.
59. Rocha BA, Fumagalli F, Gainetdinov RR, Jones SR, Ator R, Giros B, Miller GW, Caron MG (1998) Cocaine self-administration in dopamine-transporter knockout mice. Nature Neurosci 1:132-137.
60. Rolls ET (1996) The orbitofrontal cortex. Phil Trans R Soc Lond B Biol Sci 351:1433-1443.
61. 3H raclopride in the mouse in vivo. Naunyn Schmiederbergs Arch Pharmacol 340:6-12.
62. Saha GB, MacIntyre WJ, Go RT (1994) Radiopharmaceuticals for brain imaging. Semin Nucl Med 24:324-349.
63. Schmidt B, Richter-Rau G, Thoden U (1981) Addiction-like behavior with continuous self-stimulation of the mediothalamic system. Arch Psychiat Nervenkr 230:55-61.
64. Schoenbaum G, Chiba AA, Gallagher M (1998) Orbitofrontal cortex and basolateral amygdala encode expected outcomes during learning. Nature Neurosci 1:155-159.
65. Seeman P, Guan HC, Niznik HB (1989) Endogenous dopamine lowers the dopamine D2 receptor density as measured by 3H raclopride: implications for positron emission tomography of the human brain. Synapse 3:96-97.
66. Stuss DT, Benson DF (1986) The frontal lobes. New York: Raven Press.
67. Thorpe SJ, Rolls ET, Madison S (1983) The orbitofrontal cortex: neuronal activity in the behaving monkey. Exp Brain Res 49:93-115.
68. Thut G, Schultz W, Roelcke U, Nienhusmeier M, Missimer J, Maguire RP, Leenders KL (1997) Activation of the human brain by monetary reward. NeuroReport 8:1225-1228.
69. Tremblay L, Schultz W. (1999) Relative reward preference in primate orbitofrontal cortex. Nature 398:704-708.
70. Tucker DM, Luu P, Pribram KH (1995) Social and emotional self-regulation. Ann NY Acad Sci 769:213-239.
71. Volkow ND, Fowler JS, Wolf AP, Hitzemann R, Dewey S, Bendriem B, Alpert R, Hoff A (1991) Changes in brain glucose metabolism in cocaine dependence and withdrawal. Am J Psychiat 148:621-626.
72. Volkow ND, Hitzemann R, Wang G-J, Fowler JS, Wolf AP, Dewey SL (1992) Long-term frontal brain metabolic changes in cocaine abusers. Synapse 11:184-190.
73. Volkow ND, Fowler JS, Wang G-J, Hitzemann R, Logan J, Schlyer D, Dewey S, Wolf AP (1993a) Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse 14:169-177.
74. 11C raclopride binding in the human brain. J Nucl Med 34:609-613.
75. Volkow ND, Wang G-J, Hitzemann R, Fowler JS, Wolf AP, Pappas N, Biegon A, Dewey SL (1993c) Decreased cerebral response to inhibitory neurotransmission in alcoholics. Am J Psychiat 150:417-422.
76. 11C]raclopride in the human brain. Synapse 16:255-262.
77. Volkow ND, Ding Y-S, Fowler JS, Wang GJ, Logan J, Gatley SJ, Dewey SL, Ashby C, Lieberman J, Hitzemann R, Wolf AP (1995) Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in human brain. Arch Gen Psychiat 52:456-463.
78. Volkow ND, Ding Y-S, Fowler JS, Wang G-J (1996a) Cocaine addiction: hypothesis derived from imaging studies with PET. J Addict Dis 15: 55-71.
79. Volkow ND, Wang G-J, Fowler JS, Logan J, Hitzemann RJ, Ding Y-S, Pappas NS, Shea C, Piscani K (1996b) Decreases in dopamine receptors but not in dopamine transporters in alcoholics. Alcohol Clin Exp Res 20:1594-1598.
80. Volkow ND, Wang G-J, Fowler JS, Logan J, Gatley SJ, Hitzemann R, Chen AD, Pappas N (1997a) Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects. Nature 386:830-833.
81. Volkow ND, Wang GJ, Overall JE, Hitzemann R, Fowler JS, Pappas N, Frecska E, Piscani K (1997b) Regional brain metabolic response to lorazepam in alcoholics during early and late alcohol detoxification. Alcohol Clin Exp Res 21:1278-1284.
82. Wang G-J, Volkow ND, Fowler JS, Wolf AP, MacGregor R, Shea CE, Shyler D, Hitzemann R (1993) Comparison of two PET radioligands for imaging extrastriatal dopamine receptors in human brain. Synapse 15:246-249.
83. Wang G-J, Volkow ND, Fowler JS, Cervany P, Hitzemann RJ, Pappas N, Wong CT, Felder C (1999) Regional brain metabolic activation during craving elicited by recall of previous drug experiences. Life Sci 64: 775-784.
84. Weissenborn R, Whitelaw RB, Robbins TW, Everitt BJ (1998) Excitotoxic lesions of the mediodorsal thalamic nucleus attenuate intravenous cocaine self-administration. Psychopharmacology (Berlin) 140: 225-232.
85. Yeager RJ, DiGiuseppe R, Resweber PJ, Leaf R (1992) Comparison of million personality profiles of chronic residential substance abusers and a general outpatient population. Psychol Rep 71:71-79.
86. Young CD, Deutch AY (1998) The effects of thalamic paraventricular nucleus lesions on cocaine-induced locomotor activity and sensitization. Pharmacol Biochem Behav 60:753-758.